Serum leptin level and microvascular complications in type 2 diabetes

被引:1
作者
Aaty, Talaat A. Abdel [1 ]
Rezk, Mohamed M. [2 ]
Megallaa, Magdy H. [1 ]
Yousseif, Maha E. [1 ]
Kassab, Heba S. [1 ]
机构
[1] Alexandria Univ, Dept Internal Med, Unit Diabet & Metab, Fac Med, 17 Champollion St, Alexandria 21131, Egypt
[2] Alexandria Univ, Dept Chem & Clin Pathol, Fac Med, Alexandria, Egypt
来源
CLINICAL DIABETOLOGY | 2020年 / 9卷 / 04期
关键词
leptin; type; 2; diabetes; microvascular complications; ADIPOSE-TISSUE; ASSOCIATION; MECHANISMS; RISK;
D O I
10.5603/DK.2020.0025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Type 2 diabetes (T2DM) and its complications are highly prevalent in Egypt and are considered a major health problem. Insulin resistance arising from visceral obesity is the main pathological mechanism of T2DM. Leptin is an adipokine secreted from visceral adipose tissue and its level is proved to be higher in patients with T2DM, but its association with microvascular complications is not yet well-established, for this aim the present study was conducted. Methods. This cross-sectional study was conducted among 120 participants with T2DM recruited from the diabetes outpatient clinic of Alexandria Main University Hospital, Alexandria, Egypt. Each participant was subjected to full history taking, complete physical examination and laboratory investigations. Results. Serum leptin level was significantly positively correlated with diabetes duration, BMI, WC, systolic and diastolic blood pressure, FPG, HbA(1c), serum insulin level, HOMA-IR, total cholesterol, triglycerides and LDL-C. Regarding microvascular complications, serum leptin level was highly significantly positively correlated with UACR, peripheral neuropathy and retinopathy (P < 0.001) and significantly negatively correlated with e-GFR (P = 0.003). Conclusions. Serum leptin level is significantly correlated with microvascular complications in patients with T2DM in Alexandria, Egypt.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 30 条
  • [1] Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
    Abel, ED
    Peroni, O
    Kim, JK
    Kim, YB
    Boss, O
    Hadro, E
    Minnemann, T
    Shulman, GI
    Kahn, BB
    [J]. NATURE, 2001, 409 (6821) : 729 - 733
  • [2] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [4] The stomach is a source of leptin
    Bado, A
    Levasseur, S
    Attoub, S
    Kermorgant, S
    Laigneau, JP
    Bortoluzzi, MN
    Moizo, L
    Lehy, T
    Guerre-Millo, M
    Le Marchand-Brustel, Y
    Lewin, MJM
    [J]. NATURE, 1998, 394 (6695) : 790 - 793
  • [5] Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
    Bakker, Wineke
    Eringa, Etto C.
    Sipkema, Pieter
    van Hinsbergh, Victor W. M.
    [J]. CELL AND TISSUE RESEARCH, 2009, 335 (01) : 165 - 189
  • [6] Bio Ray, HUM LEPT EL KIT
  • [7] Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway
    Cha, Jin Joo
    Hyun, Young Youl
    Jee, Yih Wa
    Lee, Mi Jin
    Kang, Young Sun
    Han, Sang Youb
    Cha, Dae Ryong
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2012, 31 (03) : 177 - 185
  • [8] Leptin and the regulation of body weight in mammals
    Friedman, JM
    Halaas, JL
    [J]. NATURE, 1998, 395 (6704) : 763 - 770
  • [9] Guzik TJ, 2007, J PHYSIOL PHARMACOL, V58, P591
  • [10] Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus
    Jung, Chan-Hee
    Kim, Bo-Yeon
    Mok, Ji-Oh
    Kang, Sung-Koo
    Kim, Chul-Hee
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) : 333 - 339